Genistein
has been the focus of scientific research since 1966. Studies have shown that it
can bind to the same receptor sites as estrogen. Soybeans are the only
significant dietary source; however, the amount of soy foods necessary to
meet the body's needs can be difficult to incorporate into today's diet.
In Asia, where soy is a staple, the daily intake can be up to 20 times
that of a Western diet. Source Naturals Genistein is made from isoflavone-rich
soybean powder that yields a consistent standardized isoflavone content.
This unique chemical-free process requires approximately 400 pounds of
soybeans to yield just one pound of finished product.
Buy Genistein supplement or Prostate Power Rx
| Supplement Facts | ||
| Serving Size: 2 Tablets | ||
| Servings Per Container: 60 | ||
| Amount Per Serving | %DV | |
| Calories | 10 | |
| Total Carbohydrate | 1 g | <1%* |
| Dietary Fiber | 1 g | 4%* |
| Protein | 1 g | 2%* |
| Soylife Non-GMO Isoflavone Complex (from soy) | 2 g | † |
| Yielding: | ||
| Daidzein | 15.8 mg | † |
| Glycitein | 6.8 mg | † |
| Genistein | 2.0 mg | † |
| Total Isoflavones | 44 mg | † |
| * Percent Daily Values (%DV) are based on a 2,000
calorie diet. †Daily Value not established. |
||
Suggested Use, dose: One genistein tablet a few times a week with breakfast, or as recommended by your health care professional.
Prostate Power
Rx
is formulated with important herbs and nutrients to
provide optimal
prostate
health. Significant clinical research on prostate enlargement has been conducted
with the potent herbs in this prostate formula.

With Saw Palmetto, Pygeum, Stinging
Nettle, Quercetin, and several important Ingredients for support of normal prostate size
and urine flow
Saw Palmetto extract (standardized to contain 45% fatty acids - serenoa repens fruit)
Stinging Nettle 4:1 extract
Quercetin flavonoid extract
Rosemary 4:1 extract (Rosemarinus officinales leaf)
Beta Sitosterol
extract.
Pygeum Africanum
4:1 bark extract
Daidzein (standardized to contain 40% isoflavones)
(treatment with the
isoflavones daidzein and genistein, the estrogen-like compounds found in
soy, block prostate growth in rats)
Genistein (standardized to contain 40% isoflavones)
Lycopene from tomato
Review of health
benefit
In spite of an extensive literature on the effects of dietary genistein, questions still
exist as to its potential overall benefits as a component of the human diet.
Dietary genistein ingestion has been linked, through epidemiological and animal model
studies, with a range of potential health effects. These include
prevention of breast, colon, and prostate cancers, cardiovascular disease and post-menopausal
ailments. Genistein may also be helpful in decreasing bone loss after menopause.
Research
interpretation
Nutr Reviews. 2013. Pleiotropic effects of genistein in metabolic,
inflammatory, and malignant diseases. This soy-derived biologically
active isoflavone exhibits diverse health-promoting effects. An
increasing body of evidence shows that it influences lipid homeostasis
and insulin resistance, counteracts inflammatory cytokines, and
possesses antidiabetic properties. It also impedes cancer progression by
promoting apoptosis, inducing cell cycle arrest, modulating
intracellular signaling pathways, and inhibiting angiogenesis and
metastasis of neoplastic cells. This review summarizes the many
functions of genistein in common health disorders such as metabolic
syndrome, chronic inflammatory diseases, and cancer.
Antioxidant
Genistein appears to have excellent
antioxidant ability.
The effect of genistein supplementation on performance
and antioxidant status of Japanese quail under heat stress.
Arch Anim Nutr. 2004.
Results of the present study suggest that
supplementation with genistein can be considered to be protective by reducing
the negative effects of oxidative stress induced by heat stress in quail.
Asthma and lung
function
Genistein may be associated with improved lung function in asthma.
Atherosclerosis or hardening of the arteries, role in
heart disease
A rabbit study shows
supplementation reduces the risk for hardening of the arteries.
Cardiovascular effects of the phytoestrogen genistein.
Curr Med Chem Cardiovasc Hematol Agents. 2004.
Genistein in vitro relaxes rat arteries by a
nitric oxide dependent mechanism and enhances the dilator response to
acetylcholine of atherosclerotic arteries. Genistein supplementation improves
endothelial dysfunction induced by oophorectomy in rats and reduces infarct size
in an experimental model of myocardial ischaemia-reperfusion injury.
Furthermore, genistein in postmenopausal women increases plasma nitric oxide
breakdown products, reduces endothelin-1 levels and improves endothelial
dependent vasodilation in post-menopausal women. All these findings, taken
together, would suggest that this molecule might represent an attractive
alternative for cardiovascular protection.
Blood pressure management, use for hypertension
Chronic soy milk consumption has modest, but significant hypotensive action in
those with hypertension. This hypotensive action was correlated with the urinary
excretion of the isoflavone genistein.
Genistein helps produce more nitric oxide, a powerful chemical in
the blood stream that helps dilate blood vessels.
Cancer
Soy isoflavones
may have an important role in reducing the incidence of breast, colon,
cervix and
prostate cancers. Genistein, the predominant isoflavone found in soy, has been
shown to inhibit carcinogenesis in animal models. There is a growing body of
experimental evidence that shows the inhibition of human cancer cells by genistein
through the modulation of genes that are related to the control of cell
cycle and apoptosis.
Genistein acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis. Genistein also shows synergistic behavior with well-known anticancer drugs, such as adriamycin, docetaxel, and tamoxifen, suggesting a potential role in combination therapy.
Breast cancer
Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition
of NF-kappaB/AP-1-dependent and -independent pathways.
Int J Oncol. 2004.
The chemopreventive effect of the soy
isoflavone, genistein, has been observed through the suppression of cell
proliferation, inhibition of angiogenesis and stimulation of apoptosis in breast
carcinoma cells. Cancer metastasis consists of interdependent processes,
including cell adhesion, migration and invasion. In the present study, we
compare the effect of soy isoflavones in the form of aglycones (genistein,
daidzein and glycitein) and glucosides (genistin, daidzin and glycitin) on the
behavior of highly invasive breast cancer cells. Here we demonstrate that
genistein suppresses cell adhesion and migration by inhibiting the
constitutively active transcription factors NF-kappaB and AP-1, resulting in the
suppression of secretion of urokinase-type plasminogen activator (uPA) in breast
cancer cells. Our results suggest
that dietary soy isoflavones inhibit adhesion and motility of highly invasive
breast cancer cells by distinct signaling pathways.
Dietary phytoestrogen intake and premenopausal breast cancer risk in a German
case-control study.
Int J Cancer. 2004.
A diet high in isoflavonoids is associated with lower breast cancer risk
in Asian populations. Due to the low soy intake, dietary lignans may be the more
important phytoestrogen class in Western populations. We used a population-based
case-control study of breast cancer by age 50 in southern Germany to evaluate
the association between dietary intake of different phytoestrogens and
premenopausal breast cancer risk. Using
multivariate logistic regression, the highest vs. lowest intake quartiles of daidzein and genistein yielded significantly reduced ORs for breast
cancer risk of 0.62 and 0.47, respectively. The
protective effects of daidzein and genistein were found only for hormone
receptor-positive tumors. High intake of other isoflavonoids, e.g., formononetin
and biochanin A, as well as the sum of isoflavonoids were not associated with a
decrease in risk. Breast cancer risk significantly decreased with a high intake
of the plant lignan matairesinol but not secoisolariciresinol or the sum of plant lignans. No effect was found for total phytoestrogen intake. Our results
suggest an important role of dietary intake of daidzein and genistein, despite
low levels, as well as of matairesinol and mammalian lignans to reduce
premenopausal breast cancer risk in this study population.
Ovarian cancer
Inhibitory effect of genistein and daidzein on ovarian
cancer cell growth.
Anticancer Res. 2004.
Five ovarian cancer cell lines from Stage IIIC disease
were evaluated. Sulforhodamine B and colony formation assays were used to
analyze growth inhibitory effects of genistein and daidzein alone and with
cisplatin, paclitaxel or topotecan. Cisplatin and topotecan combined with genistein resulted in a mostly additive effect, paclitaxel was
slightly less than additive. We demonstrate an inhibitory effect of genistein on ovarian cancer cell growth.
Prostate cancer
Prostate. November 2013. Genistein enhances the efficacy of cabazitaxel
chemotherapy in metastatic castration-resistant prostate cancer cells.
Ebola virus natural treatment? not yet
Arch Virol. 2012. Inhibition of Lassa virus and Ebola virus infection in
host cells treated with the kinase inhibitors genistein and tyrphostin.
Arenaviruses and filoviruses are capable of causing hemorrhagic fever syndrome
in humans. Limited therapeutic and/or prophylactic options are available for
humans suffering from viral hemorrhagic fever. In this report, we demonstrate
that pre-treatment of host cells with the kinase inhibitors genistein and
tyrphostin AG1478 leads to inhibition of infection or transduction in cells
infected with Ebola virus, Marburg virus, and Lassa virus. In all, the results
demonstrate that a kinase inhibitor cocktail consisting of genistein and
tyrphostin AG1478 is a broad-spectrum antiviral that may be used as a
therapeutic or prophylactic against arenavirus and filovirus hemorrhagic fever.
Note: This study did not test whether administering genistein
orally would cure ebola. I am also not aware of any such human studies regarding
natural treatment for ebola.
Hot flashes, and menopause
Genistein and other flavonoids do not appear to have a significant effect in
reducing the severity of hot flashes, at least not as much as estrogen.
Lung health, asthma
Dietary intake of soy genistein is
associated with lung function in patients with asthma.
J Asthma. 2004.
To determine if micronutrient intake is associated with asthma severity, we
administered the Block food frequency questionnaire to participants in a
randomized clinical trial of the safety of influenza vaccine for asthmatics. The
nutrition substudy included 1033 participants, aged 12-75. Intake of antioxidant
vitamins, soy isoflavones, total fruits and vegetables, fats, and fiber was
compared with asthma severity at baseline, peak expiratory flow rate (PEF),
asthma symptoms and the rate of asthma exacerbations during the 2 weeks
following influenza vaccination. The only nutrient that had a consistent
association with asthma severity was genistein. Increasing consumption of genistein is associated with better lung function in
patients with asthma.
Q. What is your opinion on using Genistein Daidzein for
weaning off Premarin, which is being taken for hot flushing after a complete
hysterectomy?
A. It is difficult to predict, some women find a benefit, others do
not.
Osteoporosis
influence, bone health
Genistein, along with other isoflavones, may
help decrease bone loss after menopause.
The effects of phytoestrogen isoflavones on bone density in women: a
double-blind, randomized, placebo-controlled trial.
Am J Clin Nutr. 2004.
Isoflavone phytoestrogen therapy has been proposed as a natural
alternative to hormone replacement therapy. The objective of the study was to determine the effect on bone
density of a red clover-derived isoflavone supplement that provided a daily dose
of 26 mg biochanin A, 16 mg formononetin, 1 mg genistein, and 0.5 mg daidzein
for 1 y. Effects on biochemical markers of bone turnover and body composition
were also studied. Women aged 49-65 y were enrolled in a
double-blind, randomized, placebo-controlled trial; 177 completed the trial.
Bone density, body composition, bone turnover markers, and diet were measured at
baseline and after 12 mo. Loss of lumbar spine bone mineral content and
bone mineral density was significantly
lower in the women taking the isoflavone supplement than in those taking the
placebo. There were no significant treatment effects on hip bone mineral content
or bone mineral density, markers of bone resorption, or body composition, but
bone formation markers were significantly increased in the intervention group compared with placebo in postmenopausal
women. Interactions between treatment group and menopausal status with respect
to changes in other outcomes were not significant. These data
suggest that, through attenuation of bone loss, isoflavones have a potentially
protective effect on the lumbar spine in women
Prostate gland health
Genistein levels in prostate tissue are
lower in those who have prostate cancer or an enlarged prostate.
Role in thyroid health and function
In a 2007 clinical trial, Italian researchers found that genistein supplements,
along with calcium and vitamin D, appeared to help boost bone mass in
postmenopausal women with thinning bones.In this latest study, the researchers
evaluated data from the same clinical trial -- this time looking at whether the
genistein supplements had any effects on the women's thyroid function.The
question stems from lab research showing that genistein and other isoflavones
may decrease thyroid-hormone production. Thyroid hormones help govern
metabolism, and an underactive thyroid gland, called hypothyroidism, can lead to
problems like fatigue, weight gain and intolerance to cold.The earlier research
suggested that isoflavones can affect thyroid hormones by interfering with
iodine, which is needed for thyroid- hormone production, explained Dr. Francesco
Squadrito of the University of Messina, the senior researcher on the
study.However, he told Reuters Health by email, those studies used genistein
doses that were 10 to 250 times higher than the doses used in his team's
clinical trial -- 54 milligrams (mg) per day.Squadrito and his colleagues found
that among 77 study participants they followed for three years, those who used
the genistein supplement during that time showed no overall differences in
thyroid function compared with women who were given a placebo.The findings are
published in the Journal of Clinical Endocrinology and Metabolism.According to
Squadrito, it is not surprising that studies would find thyroid effects of very
high doses of genistein. However, he said, women are unlikely to consume such
levels from soy-protein products, or from soy foods like tofu.As far as thyroid
function is concerned, Squadrito said, "it is possible to conclude that
genistein therapy is safe in postmenopausal women -- at least at the dose of 54
mg a day."However, soy contains several types of isoflavones, and more studies
are needed to establish the safety of those compounds, according to Squadrito
and his colleagues.SOURCE: Journal of Clinical Endocrinology and Metabolism,
online March 31, 2010.
Uterine sarcoma
Anticancer Res. 2015. Genistein
Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms.
The six major subclasses of flavonoids include:
Anthocyanidins (e.g., cyanidin, pelargonidin)
Catechins or flavanols (e.g., epicatechin, gallocatechin)
Flavones (e.g., apigenin, luteolin)
Flavonols (e.g., kaempferol, myricetin, quercetin)
Flavanones (e.g., hesperidin, naringenin)
Isoflavones (such as genistein, daidzein,
biochanin).
Chemistry,
synthesis and metabolism
Genistein, (also known as 4',5,7-trihydroxyisoflavone) is a common precursor in the biosynthesis
of antimicrobial phytoalexins and phytoanticipins in legumes.
Genistein is
synthesized in plants from the flavanone naringenin. It is a phytoestrogen with a wide
variety of pharmacological effects in animal cells, including tyrosine kinase
inhibition.
Genistein studies
Anticancer therapeutic potential of soy isoflavone,
genistein.
Adv Exp Med Biol. 2004.
Genistein occurs as a glycoside (genistin) in
the plant family Leguminosae, which includes the soybean (Glycine max). A
significant correlation between the serum/plasma level of genistein and the
incidence of gender-based cancers in Asian, European and American populations
suggests that it may reduce the risk of tumor formation. It inhibits protein tyrosine kinase (PTK), which is involved in
phosphorylation of tyrosyl residues of membrane-bound receptors leading to
signal transduction, and it inhibits topoisomerase II, which participates in DNA
replication, transcription and repair. By blocking the activities of PTK,
topoisomerase II and matrix metalloprotein (MMP9) and by down-regulating the
expression of about 11 genes, including that of vascular endothelial growth
factor (VEGF), genistein can arrest cell growth and proliferation, cell cycle at
G2/M, invasion and angiogenesis. Furthermore, it can alter the expression
of gangliosides and other carbohydrate antigens to facilitate their immune
recognition. Genistein acts synergistically with drugs such as tamoxifen,
cisplatin, 1,3-bis 2-chloroethyl-1-nitrosourea (BCNU), dexamethasone,
daunorubicin and tiazofurin, and with bioflavonoid food supplements such as
quercetin, green-tea catechins and black-tea thearubigins. It can augment
the efficacy of radiation for breast and prostate carcinomas. Because it
increases melanin production and tyrosinase activity, genistein can protect
melanocytes of the skin of Caucasians from UV-B radiation-induced melanoma.
Although genistein has many potentially therapeutic actions against cancer, its
biphasic bioactivity (inhibitory at high concentrations and activating at low
concentrations) requires caution in determining therapeutic doses alone or in combination with chemotherapy, radiation therapy,
and/or immunotherapies. Several biotechnological firms in Japan, Australia and in the United
States (e.g., Nutrilite) manufacture genistein as a natural supplement under
quality controlled and assured conditions.
Phytoestrogen tissue levels in benign prostate
hyperplasia and prostate cancer and their association with prostate diseases.
Urology. 2004 Oct.
Prostate tissue samples of men
consuming a Western diet who underwent surgery for prostate enlargement
or prostate cancer were collected and frozen. In the
tissue samples, the enterolactone and genistein levels were determined. We subsequently compared
the tissue levels in patients with prostate enlargement and prostate cancer and
studied the impact of enterolactone and genistein on prostate volume.
The enterolactone tissue levels were comparable in patients with prostate
enlargement and prostate cancer and revealed no correlation to prostate volume.
The genistein tissue levels tended to be lower in patients with prostate cancer
compared with the entire prostate enlargement group. In addition, the genistein
tissue levels were significantly greater in men with small-volume prostate
enlargement compared with those with large-volume prostate enlargement. Our data suggest an involvement of genistein in the pathogenesis of prostate enlargement and, possibly, of prostate
cancer. The impact of enterolactone is currently unknown.
Genistein supplementation inhibits atherosclerosis with
stabilization of the lesions in hypercholesterolemic rabbits.
J Korean Med Sci. 2004 Oct.
After
provocation of atherosclerosis with hyperlipidemic diet, rabbits were
divided as hyperlipidemic diet group (HD), normal diet group (ND) and
hyperlipidemic plus genistein diet group (HD + genistein) for 4 and half months.
The average cross sectional area of atherosclerotic lesion was 0.269 mm2 after
provocation. The lesion was progressed by continuous hyperlipidemic diet (10.06
mm2) but was increased mildly by genistein (0.997 mm2), and decreased by normal
diet. The ratio of macrophages to smooth muscle cells in the lesion
was not changed by genistein supplementation. The western blotting showed
reduction of MMP-3 expression in HD+genistein and ND groups than HD group. The
inhibition of atherogenesis by genistein might be due to improved
endothelial function rather than direct action on macrophages and/or smooth
muscle cells in the lesion, since endothelial dysfunction by lipid peroxidation
was the main atherogenic factor in the hypercholesterolemic rabbits. The
genistein supplementation also suggests that it helps the stabilization of the
atherosclerotic lesion by inhibition of MMP-3 expression.
Phytoestrogenic isoflavones daidzein and genistein
reduce glucose-toxicity-induced cardiac contractile dysfunction in ventricular
myocytes.
Endocr Res. 2004.
Epidemiological evidence suggests a reduction in the incidence of coronary
heart disease, cancer and osteoporosis in populations with a high dietary intake
of plant estrogen or phytoestrogen. The clinical benefit of phytoestrogens in
cereals, vegetables and medicinal plants is attracting increasing attention for
the general public. In the present study, we examined the effect of
phytoestrogenic isoflavones daidzein and genistein on glucose toxicity-induced
cardiac mechanical malfunction simulating diabetic cardiomyopathy. Adult rat
ventricular myocytes were isolated and maintained for 24 hours in normal or high
glucose medium in the absence or presence of isoflavones daidzein or genistein. Collectively, these
data suggest that the phytoestrogenic isoflavones daidzein and genistein may
reduce glucose toxicity-induced cardiac mechanical dysfunction and thus possess
therapeutic potential against diabetes-associated cardiac defects.
Soy isoflavones and cancer prevention.
Sarkar FH, Li Y. Wayne State University School of Medicine, Detroit, MI
Cancer Invest. 2003.
Epidemiological studies have shown a significant difference in cancer
incidence among different ethnic groups, which is believed to be partly
attributed to dietary habits. The incidences of breast and prostate cancers are
much higher in the United States and European countries compared with Asian
countries such as Japan and China. One of the major differences in diet between
these populations is that the Japanese and the Chinese consume a traditional
diet high in soy products. Soy isoflavones have been identified as dietary
components having an important role in reducing the incidence of breast and
prostate cancers. Genistein, the predominant isoflavones found in soy, has been
shown to inhibit carcinogenesis in animal models. Experimental evidence shows the inhibition of human cancer cells by genistein through the modulation of genes that are related to the control of
cell cycle and apoptosis. Moreover, it has been shown that genistein inhibits
the activation of NF-kappa B and Akt signaling pathways, both of which are known
to maintain a homeostatic balance between cell survival and apoptosis. Genistein
is commonly known as phytoestrogen, which targets estrogen- and
androgen-mediated signaling pathways in the processes of carcinogenesis.
Furthermore, genistein has been found to have antioxidant property, and shown to
be a potent inhibitor of angiogenesis and metastasis. Taken together, both in
vivo and in vitro studies have clearly shown that genistein, one of the major
soy isoflavones, is a promising reagent for cancer chemoprevention and/or
treatment. In this article, we attempt to provide evidence for these effects of
genistein in a succinct manner to provide comprehensive state-of-the-art
knowledge of the biological and molecular effects of the isoflavone genistein in
cancer cells.
Other products online
Purchase Genistein
supplement
Facts:
Amount Per 2 tablets:
Isoflavone-Rich 2 grams
Soybean Powder ( Soylife ) Yielding:
Daidzein 34 mg
Glycitein 20 mg
Genistein 8 mg
Total Isoflavones 62 mg